Yilmaz Mahshid

Filings at 2 companies/Chief financial officer · Egetis Therapeutics AB (publ)

5 of 11 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 11. Reading the whole list, and the full company page behind every filing, is part of the subscription. So are this filer’s key figures — how many filings and open-market purchases they reported, and over which period — and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The 5 most recent of 11 visible filings, newest first.

Egetis Therapeutics AB (publ) Chief financial officer
232,266 SEKOpen-market buy
TradedNov 26, 2025FiledDec 1, 2025
Egetis Therapeutics AB (publ) Chief financial officer
188,300 SEKOpen-market buy
TradedJul 15, 2025FiledJul 17, 2025
Egetis Therapeutics AB (publ) Chief financial officer
507,682 SEKOpen-market sale
TradedJan 7, 2025FiledJan 9, 2025
Egetis Therapeutics AB (publ) Chief financial officer
653,499 SEKOpen-market sale
TradedJan 8, 2025FiledJan 9, 2025
Egetis Therapeutics AB (publ) Chief financial officer
268,333 SEKOpen-market sale
TradedJan 9, 2025FiledJan 9, 2025